Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NMAD · NASDAQ · Pharmaceutical Preparations
$2.56+0.305 (+13.53%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Nomad Power Solutions (NMAD) · oqro.io/stocks/NMAD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
Director purchased ~$42K of NMAD shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 19, 2026
Director purchased ~$8.4K of NMAD shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 19, 2026
Director purchased ~$5.9K of NMAD shares in the open marketSource5%+ stake · Stake as of Nov 6, 2026 · Filed Nov 16, 2026
Beneth Capital LLC now owns 9.3% of NMAD as a passive investorSource5%+ stake · Stake as of Nov 9, 2026 · Filed Nov 16, 2026
Geordan Pursglove now owns 9.8% of NMAD as a passive investorSource5%+ stake · Stake as of Sep 3, 2026 · Filed Oct 28, 2026
North York Ltd now owns 9.8% of NMAD as a passive investorSource